Martek Announces Third Quarter 2009 Financi...(608 17259 15922 ...),Health

Date:9/2/2009

,608 17,259 15,922 ----- ----- ------ ------ Net income $8,928 $9,332 $29,551 $27,203 ====== ===== ======= ======= Basic earnings per share $0.27 $0.28 $0.89 $0.83 ==== ==== ===== ===== Diluted earnings per share $0.27 $0.28 $0.89 $0.82 ==== ==== ===== ===== Shares used in computing basic earnings per share 33,234 33,016 33,191 32,892 Shares used in computing diluted earnings per share 33,346 33,408 33,346 33,235

    Unaudited Condensed Consolidated Balance Sheets Data

                                                     July 31,  October 31,
                                                        2009         2008
                                                        ----         ----

     Assets:
        Cash and cash equivalents                   $129,345     $102,495
        Short-term investments                         7,383            -
        Accounts receivable, net                      37,318       40,438
        Inventories, net                             125,339       99,553
        Other current assets                           3,029        4,866
        Property, plant and equipment, net           255,651      265,900
        Deferred tax asset                            20,936       38,356
        Long-term investments                          4,197       11,336
        Goodwill and other, net                       95,110       83,037
                                                      ------       ------
     Total assets                                   $678,308     $645,981
                                              
'/>"/>
SOURCE  Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Martek Announces Third Quarter 2007 Financial Results
3. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
4. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
5. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
6. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
7. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
8. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
9. Martek Announces Settlement of Class Action Lawsuit
10. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
11. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation